Join us each month for
Roundtable: Advancing Microbiome Science to Clinical Practice
You’ll meet thought leaders from pharma, biotech, academia, nonprofits, and government who are creating new products and navigating the commercial and regulatory landscape. As we all work to address fresh opportunities in a changing world, this is a great environment for sharing your work and your challenges.
This series is hosted by the Consortium on Translational Research in the Microbiome, a collaboration between Westchester Biotech Project and the Institute for Life Science Entrepreneurship (ILSE), based at Kean University.
Until it’s safe to gather in person, join us virtually! Interested in speaking at one of our programs? Reach out! info@westchesterbiotechproject.org
Who We Are.
The CTRM was established in 2017 through mutual interests in the human microbiome and the professional connections of the Institute for Life Science Entrepreneurship at Kean University in New Jersey, the Office of Research at the City University of New York and the Westchester Biotech Project.
Each individual on the committee, and the organizations they represent, appreciate the clinical potential of research on the human microbiome. And, each wants to work collaboratively in the development of enabling technologies and know-how, as a basis for the translation of scientific findings into effective medical breakthroughs.
Finally, all of us are dedicated to accelerating the discovery and development of new treatments to ensure better health and address unmet needs.
Our Next Session:
November 2, 2022 10:00 AM EDT
Planning Session for Spring 2023 Conference
Contact info@westchesterbiotechproject.org
to participate
Join Our Email List
Scroll all the way down to submit - Thanks!
CTRM Co-Chairs:
Keith Bostian Ph.D.
Keith Bostian, Ph.D., CEO, Institute for Life Science Entrepreneurship
Dr. Bostian is an entrepreneur scientist with a distinguished career in industry and academia. He is a founder of nine biopharma companies, an inventor on numerous patents and publications in drug discovery and genomics, and has led efforts resulting in a number of drugs and clinical candidates in infectious and inflammatory diseases. He is also a founder of the Institute for Life Science Entrepreneurship, a member of the Advisory Board for CARB-X, and a fellow of the American Academy for Microbiology.
He has held senior executive positions in numerous life science companies including Kemin Industries, as President and CEO of the European pharma subsidiary, and Vanta Bioscience. He is the founder of Microcide Pharmaceuticals, Iconix Pharmaceuticals, and Mpex Pharmaceuticals, and The Institute for Life Science Entrepeneurship.
The Institute for Life Science Entrepreneurship (ILSE) was developed to serve as a knowledge hub, designed to connect scientists in academia and industry, and promote translational research in the life sciences. Prior to its founding at Kean University, he held faculty positions at Brown University.
Adela Bonoiu Ph.D., CSO, Founder, Catena Biologics LLC
Adela Bonoiu Ph.D.
Dr. Bonoiu has expertise is Nanomedicine, Cell and Gene Therapy, Chronic pain, Vaccine Development, Data analytics and Regenerative Medicine. Previously Assistant Professor at University at Buffalo, she has published more than 25 papers with 1500 citations and owns US patents. She is an active member of Boston Biotech community participating in discussion panels, symposia and webinars.
Catena Biologics is a consulting boutique, specializing in Life Sciences consulting and data science services. The company offers visualization tools for Healthcare companies to increase productivity and multidisciplinary collaborations. Internal expertise spans from cancer and microbiome to data science and personalized medicine.